| Company Name: | Medifast, Incorporated | | Ticker Symbol: | MED | | | WWW Address: | www.medifastdiet.com | | CEO: | Michael S. McDevitt | | No. of Employees: | 290 | | Common Issue Type: | CS | | Business Description: | The Company is engaged in the production, distribution and sale of weight management and disease management products and other consumable health and diet products.
|
| | | Industry Information: | SPECIALTY RETAIL - Specialty Retal, Other [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 27.62 |  0.05 | 27.61 | 27.66 | 27.85 | 27.94 | 27.32 | 275731 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 425.3 | 15.4 | 2.16 | 0.38 | 0.00 | 41.8 | 0.0 | 28.67 - 3.63 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 27.57 | $ | | PE Ratio - LTM | 41.8 | |
| Market Capitalisation | 424.1 | mil |
| Latest Shares Outstanding | 15.4 | mil |
| Earnings pS (EPS) | 0.38 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 363,603 | $ |
| Effective Tax Rate | 30.8 | % |
| Float | 11.7 | mil |
| Float as % of Shares Outstanding | 76.9 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 65.30 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 79.6 | % |
| EBITDA Margin | 14.3 | % |
| Pre-Tax Profit Margin | 10.6 | % |
| Assets Turnover | 2.6 | % |
| Return on Assets (ROA) | 15.9 | % |
| Return on Equity (ROE) | 20.4 | % |
| Return on Capital Invested (ROCI) | 18.2 | % |
| Current Ratio | 4.2 | |
| Leverage Ratio (Assets/Equity) | 1.3 | |
| Interest Cover | 54.4 | |
| Total Debt/Equity (Gearing Ratio) | 0.13 | |
| LT Debt/Total Capital | 10.0 | % |
| Working Capital pS | 1.66 | $ |
| Cash pS | 1.06 | $ |
| Book-Value pS | 3.15 | $ |
| Tangible Book-Value pS | 2.87 | $ |
| Cash Flow pS | 0.97 | $ |
| Free Cash Flow pS | 1.02 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 8.76 | |
| Price/Tangible Book Ratio | 9.60 | |
| Price/Cash Flow | 28.5 | |
| Price/Free Cash Flow | 26.9 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 3.3 | 102 | 6,117 | 5,257 |
| 4 Weeks | 28.67 | 22.15 | 22.02 | 25.2 | 117 | 7,008 | 112,124 |
| 13 Weeks | 28.67 | 16.02 | 18.58 | 48.4 | 138 | 7,586 | 455,149 |
| 26 Weeks | 28.67 | 7.74 | 9.60 | 187.2 | 239 | 6,949 | 861,632 |
| 52 Weeks | 28.67 | 3.63 | 4.25 | 548.7 | 526 | 4,390 | 1,088,676 |
| YTD | 28.67 | 3.81 | - | 399.5 | 408 | 4,749 | 1,073,245 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 27.57 | 27.31 | 23.64 | 16.18 | 13.00 | 2.16 | 2.19 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 37.37 | 95.5 | 22.22 |
| Income | 28.22 | 81.2 | 17.22 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 32.08 | NA | 56.47 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 28.02 | NA | 15.46 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 49.3 | 65.0 | 25.9 |
| Earnings % | 98.8 | 121.7 | 41.6 |
| EPS % | 87.5 | 109.1 | 35.7 |
| EPS $ | 0.28 | 0.12 | 0.10 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 24.82 |
| Current Ratio | 2.5 |
| Quick Ratio (Acid Test) | 0.4 |
| Liquidity Ratio (Cash) | 0.34 |
| Receivables Turnover | 162.1 |
| Average Collection Period | 2 |
| Working Capital/Equity | 33.2 |
| Working Capital pS | 0.87 |
| Cash-Flow pS | 0.69 |
| Free Cash-Flow pS | -0.13 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 22.86 |
| Financial Leverage Ratio (Assets/Equity) | 1.3 |
| Debt Ratio | 25.2 |
| Total Debt/Equity (Gearing Ratio) | 0.20 |
| LT Debt/Equity | 0.11 |
| LT Debt/Capital Invested | 10.2 |
| LT Debt/Total Liabilities | 33.5 |
| Interest Cover | 22.4 |
| Interest/Capital Invested | 0.86 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 8.86 |
| Tobin's Q Ratio | 8.31 |
| Current P/E Ratio - LTM | 41.80 |
| Enterprise Value (EV)/EBITDA | 33.98 |
| Enterprise Value (EV)/Free Cash Flow | -270.63 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 9.60 |
| Price/Book Ratio - LTM | 8.76 |
| Price/Cash Flow Ratio | 28.5 |
| Price/Free Cash Flow Ratio - LTM | 26.9 |
| Price/Sales Ratio | 2.93 |
| P/E Ratio (1 month ago) - LTM | 35.4 |
| P/E Ratio (26 weeks ago) - LTM | 21.3 |
| P/E Ratio (52 weeks ago) - LTM | 11.8 |
| 5-Y High P/E Ratio | 102.1 |
| 5-Y Low P/E Ratio | 8.8 |
| 5-Y Average P/E Ratio | 23.5 |
| Current P/E Ratio as % of 5-Y Average P/E | 178 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 41.8 |
| PER SHARE FIGURES |
| LT Debt pS | 0.30 |
| Current Liabilities pS | 0.59 |
| Tangible Book Value pS - LTM | 2.87 |
| Book Value pS - LTM | 3.15 |
| Capital Invested pS | 2.76 |
| Cash pS - LTM | 1.06 |
| Cash Flow pS - LTM | 0.97 |
| Free Cash Flow pS - LTM | 1.02 |
| Earnings pS (EPS) | 0.38 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -1.85 |
| Free Cash Flow Margin 5YEAR AVG | 0.05 |
| Net Profit Margin | 5.2 |
| Net Profit Margin - 5YEAR AVRG. | 5.7 |
| Equity Productivity | 2.76 |
| Return on Equity (ROE) | 14.2 |
| Return on Equity (ROE) - 5YEAR AVRG. | 13.5 |
| Capital Invested Productivity | 2.48 |
| Return on Capital Invested (ROCI) | 12.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 11.7 |
| Assets Productivity | 2.20 |
| Return on Assets (ROA) | 10.6 |
| Return on Assets (ROA) - 5YEAR AVRG. | 10.0 |
| Gross Profit Margin | 79.6 |
| Gross Profit Margin - 5YEAR AVRG. | 79.3 |
| EBITDA Margin - LTM | 14.3 |
| EBIT Margin - LTM | 10.8 |
| Pre-Tax Profit Margin | 7.4 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 8.3 |
| Effective Tax Rate | 30.8 |
| Effective Tax Rate - 5YEAR AVRG. | 32.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 202 |
| Revenue per Employee | 363,603 |
| Net Income per Employee | 18,741 |
| Average Collection Period | 2 |
| Receivables Turnover | 162.1 |
| Day's Inventory Turnover Ratio | 200 |
| Inventory Turnover | 1.8 |
| Inventory/Sales | 13.1 |
| Accounts Payble/Sales | 3.47 |
| Assets/Revenue | 0.45 |
| Net Working Capital Turnover | 8.32 |
| Fixed Assets Turnover | 3.54 |
| Total Assets Turnover | 2.2 |
| Revenue per $ Cash | 57.28 |
| Revenue per $ Plant | 4.86 |
| Revenue per $ Common Equity | 2.76 |
| Revenue per $ Capital Invested | 2.48 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 68.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 66.6 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |